EverSource Wealth Advisors
SGP icon

EverSource Wealth Advisors’s SpyGlass Pharma SGP Stock Holding History

EverSource Wealth Advisors’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78 Buy
+3
New +$74 ﹤0.01% 4427

Other funds holding SGP

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

EverSource Wealth Advisors's SGP Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in SpyGlass Pharma (SGP) in Q3 2026: 3 shares worth $78. The stake represents ﹤0.01% of the portfolio and ranks #4427 among its holdings.

20 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • EverSource Wealth Advisors held 3 shares of SpyGlass Pharma worth $78 as of Q3 2026.
  • SpyGlass Pharma was a new EverSource Wealth Advisors position in Q3 2026.
  • SpyGlass Pharma made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4427 holding.
  • 20 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.